Hallucinogen persisting perception disorder and the serotonergic system: A comprehensive review including new MDMA-related clinical cases

doi:10.1016/j.euroneuro.2014.05.008

Paper

Hallucinogen persisting perception disorder and the serotonergic system: A comprehensive review including new MDMA-related clinical cases

Published Aug 1, 2014 · Ruud P W Litjens, T. Brunt, Gerard-Jan Alderliefste

European Neuropsychopharmacology

Q1 SJR score

62

Citations

6

Influential Citations

Full textSemantic Scholar

Abstract

Abstract hidden due to publisher request; this does not indicate any issues with the research. Click the full text link above to read the abstract and view the original source.

Literature Review

Study Snapshot

Ecstasy (MDMA) use may induce symptoms of hallucinogen persisting perception disorder (HPPD), a drug-induced condition characterized by inaccurate visual representations.

PopulationOlder adults (50-71 years)

Sample size24

MethodsObservational

OutcomesBody Mass Index projections

ResultsSocial networks mitigate obesity in older groups.

Sign up to use Study Snapshot

Consensus is limited without an account. Create an account or sign in to get more searches and use the Study Snapshot.

Create an account

Hallucinogen persisting perception disorder and the serotonergic system: A comprehensive review including new MDMA-related clinical cases

Sign up to use Study Snapshot

References

Citations